Breast cancer index and prediction of benefit from extended endocrine therapy in breast cancer patients treated in the Adjuvant Tamoxifen—to offer more? (aTTom) trial

J M S Bartlett, D C Sgroi, K Treuner, Y Zhang, I Ahmed, T Piper, R Salunga, E F Brachtel, S J Pirrie, C A Schnabel, D W Rea

Research output: Contribution to journal › Article › peer-review

24 Citations (Scopus)
163 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Breast cancer index and prediction of benefit from extended endocrine therapy in breast cancer patients treated in the Adjuvant Tamoxifen—to offer more? (aTTom) trial'. Together they form a unique fingerprint.

Medicine & Life Sciences